Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2018 April;109(2) > Minerva Medica 2018 April;109(2):116-25

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

REVIEW  


Minerva Medica 2018 April;109(2):116-25

DOI: 10.23736/S0026-4806.17.05446-5

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

The current role of renal biopsy in diabetic patients

Sheila BERMEJO 1, 2, 3, Julio PASCUAL 1, 4, María J. SOLER 1, 4

1 Department of Nephrology, Hospital del Mar, Barcelona, Spain; 2 Department of Nephrology, Fundació Althaia, Manresa, Spain; 3 Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain; 4 Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain


PDF  


Diabetes mellitus (DM) is a worldwide health problem due to its high prevalence, incidence and impact on patient morbidity and mortality. Chronic kidney disease (CKD) is one of the most important complications of DM. The indication of renal biopsy in diabetic patients is a widely debated topic and the final decision is usually individualized. The results of renal biopsy in diabetic patients can be classified into three groups: diabetic nephropathy (DN), non-diabetic renal disease (NDRD) or DN plus NDRD (mixed forms). Renal involvement in DN has been widely studied and different pathological classifications have been proposed. Some groups demonstrated a relationship between the pathological classifications in DN and renal prognosis. However, to our knowledge renal biopsy in diabetic patients with DN has not demonstrated an impact on their survival and renal prognosis. Some recent studies suggest that non-proteinuric diabetic patients may be affected of DN. In addition, kidney biopsy in DN under new treatments may have a fundamental role in assessing renal protection or even regression of diabetic histological lesions. On the other hand, the accurate and early diagnosis and subsequent treatment of diabetic patients with NDRD has been shown to benefit both their renal and patient prognosis. Renal involvement in patients with DM is very heterogeneous. Thus, the role of renal biopsy in diabetic patients is becoming increasingly important.


KEY WORDS: Diabetes mellitus - Biopsy - Diabetic nephropathies

inizio pagina

Publication History

Issue published online: March 9, 2018
Article first published online: November 7, 2017
Manuscript accepted: November 6, 2017
Manuscript received: October 1, 2017

Per citare questo articolo

Bermejo S, Pascual J, Soler MJ. The current role of renal biopsy in diabetic patients. Minerva Med 2018;109:116-25. DOI: 10.23736/S0026-4806.17.05446-5

Corresponding author e-mail

msoler@parcdesalutmar.cat